keyword
https://read.qxmd.com/read/38616514/physiologically-based-pharmacokinetic-modelling-guided-dose-evaluations-of-nirmatrelvir-ritonavir-in-renal-impairment-for-the-management-of-covid-19
#21
JOURNAL ARTICLE
Tat Ming Ng, Ziteng Wang, Eric Chun Yong Chan
We aimed to address factors contributing to the pharmacokinetic changes of nirmatrelvir/ritonavir in renal impaired (RI) patients and recommend dosing adjustment via a physiologically-based pharmacokinetic (PBPK) modelling approach. A PBPK model of nirmatrelvir/ritonavir was developed via Simcyp® Simulator. Sensitivity analysis of the influence of hepatic CYP3A4 intrinsic clearance and abundance, as well as hepatic non-CYP3A4 metabolism (other human liver microsomes [HLM] CLint ) was performed to evaluate the effects of RI on oral clearance of nirmatrelvir...
April 14, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38615716/safety-of-native-glucose-dependent-insulinotropic-polypeptide-in-humans
#22
JOURNAL ARTICLE
Mads M Helsted, Nina L Schaltz, Lærke S Gasbjerg, Mikkel B Christensen, Tina Vilsbøll, Filip K Knop
In this systematic review, we assessed the safety and possible safety events of native glucose-dependent insulinotropic polypeptide (GIP)(1-42) in human studies with administration of synthetic human GIP. We searched the PubMed database for all trials investigating synthetic human GIP(1-42) administration. A total of 67 studies were included. Study duration ranged from 30minutes to 6 days. In addition to healthy individuals, the studies included individuals with impaired glucose tolerance, type 2 diabetes, type 1 diabetes, chronic pancreatitis and secondary diabetes, latent autoimmune diabetes in adults, diabetes caused by a mutation in the hepatocyte nuclear factor 1-alpha gene, end-stage renal disease, chronic renal insufficiency, critical illness, hypoparathyroidism, or cystic fibrosis-related diabetes...
April 12, 2024: Peptides
https://read.qxmd.com/read/38613610/time-varying-clearance-in-milrinone-pharmacokinetics-from-premature-neonates-to-adolescents
#23
JOURNAL ARTICLE
Conor J O'Hanlon, Anita Sumpter, Brian J Anderson, Jacqueline A Hannam
BACKGROUND AND OBJECTIVES: Milrinone is an inotrope and vasodilator used for prophylaxis or treatment of low cardiac output syndrome after weaning from cardiopulmonary bypass (CPB). It is renally eliminated and has an acceptable therapeutic range of 100-300 μg/L, but weight-based dosing alone is associated with poor target attainment. We aimed to develop a population pharmacokinetic model for milrinone from premature neonates to adolescents, and to evaluate how age, renal function and recovery from CPB may impact dose selection...
April 13, 2024: Clinical Pharmacokinetics
https://read.qxmd.com/read/38608159/a-%C3%AE-galactosidase-activated-fluorogenic-reporter-for-the-detection-of-gastric-cancer-in-vivo-and-in-urine
#24
JOURNAL ARTICLE
Mengya Yu, Zhenqi Meng, Shujuan Yi, Jianjiao Chen, Weiping Xu, Bankang Ruan, Junjian Wang, Fanghai Han, Jiaguo Huang
Although gastric cancer (GC) is one of the most frequent malignant tumors in the digestive tract with high morbidity and mortality, it remains a diagnostic dilemma due to its reliance on invasive biopsy or insensitive assays. Herein, we report a fluorescent gastric cancer reporter (FGCR) with activatable near-infrared fluorescence (NIRF) signals and high renal-clearance efficiency for the detection of orthotopic GC in a murine model via real-time imaging and remote urinalysis. In the presence of gastric-tumor-associated β-galactosidase (β-Gal), FGCR can be fluorescently activated for in vivo NIRF imaging...
April 12, 2024: Analytical Chemistry
https://read.qxmd.com/read/38606716/design-synthesis-and-evaluation-of-18-f-bibd-300-as-a-positron-emission-tomography-tracer-for-poly-adp-ribose-polymerase-1
#25
JOURNAL ARTICLE
Wei Zheng, Yong Huang, Yi Xie, Tingyu Yang, Xuebo Cheng, Hualong Chen, Chengze Li, Zeng Jiang, Ziyue Yu, Zhongjing Li, Lu Zhang, Leilei Yuan, Yajing Liu, Ying Liang, Zehui Wu
Compounds 8a - j were designed to adjust the mode of interaction and lipophilicity of FTT by scaffold hopping and changing the length of the alkoxy groups. Compounds 8a , 8d , 8g , and BIBD-300 were screened for high-affinity PARP-1 through enzyme inhibition assays and are worthy of further evaluation. PET imaging of MCF-7 subcutaneous tumors with moderate expression of PARP-1 showed that compared to [18 F]FTT, [ 18 F]8a , [ 18 F]8d , and [ 18 F]8g exhibited greater nonspecific uptake, a lower target-to-nontarget ratio, and severe defluorination, while [18 F]BIBD-300 exhibited lower nonspecific uptake and a greater target-to-nontarget ratio...
April 12, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38599715/water-conservation-overrides-osmotic-diuresis-during-sglt2-inhibition-in-patients-with-heart%C3%A2-failure
#26
RANDOMIZED CONTROLLED TRIAL
Adriana Marton, Seyed Ehsan Saffari, Manfred Rauh, Ruo-Ning Sun, Armin M Nagel, Peter Linz, Tzy Tiing Lim, Kaoru Takase-Minegishi, Anastacia Pajarillaga, Sharon Saw, Norihiko Morisawa, Wan Keat Yam, Shintaro Minegishi, John J Totman, Serena Teo, Louis L Y Teo, Choon Ta Ng, Kento Kitada, Johannes Wild, Jean-Paul Kovalik, Friedrich C Luft, Peter J Greasley, Calvin W L Chin, David K L Sim, Jens Titze
BACKGROUND: Sodium-glucose cotransporter 2 inhibitors are believed to improve cardiac outcomes due to their osmotic diuretic potential. OBJECTIVES: The goal of this study was to test the hypothesis that vasopressin-driven urine concentration overrides the osmotic diuretic effect of glucosuria induced by dapagliflozin treatment. METHODS: DAPA-Shuttle1 (Hepato-renal Regulation of Water Conservation in Heart Failure Patients With SGLT-2 Inhibitor Treatment) was a single-center, double-blind, randomized, placebo-controlled trial, in which patients with chronic heart failure NYHA functional classes I/II and reduced ejection fraction were randomly assigned to receive dapagliflozin 10 mg daily or placebo (1:1) for 4 weeks...
April 16, 2024: Journal of the American College of Cardiology
https://read.qxmd.com/read/38596427/ceftriaxone-pharmacokinetics-and-pharmacodynamic-target-attainment-for-three-pediatric-patients-receiving-continuous-kidney-replacement-therapy
#27
JOURNAL ARTICLE
H Rhodes Hambrick, Francisco Cervantes, Min Dong, Peter Tang, Trent Arbough, Alexander A Vinks, Tomoyuki Mizuno, Stuart L Goldstein, Jennifer Kaplan, Sonya Tang Girdwood
Ceftriaxone is used commonly for sepsis, including in children requiring continuous kidney replacement therapy (CKRT). No reports exist of pharmacokinetic (PK) parameters for children receiving ceftriaxone on CKRT. We enrolled children admitted to our pediatric intensive care unit (PICU) who received CKRT for >24 hours and received >1 dose of ceftriaxone while on and off CKRT. We measured free ceftriaxone -concentrations from residual blood samples then used Bayesian estimation with PK modeling software to generate concentration-time profiles and determine PK parameters and the percentage of time free ceftriaxone concentrations were above 1× or 4× MIC (% f T >MIC)...
April 2024: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/38596266/renoprotective-strategies
#28
EDITORIAL
Vaia D Raikou
Kidney disease remains a condition with an increasing incidence, high morbidity and mortality associated with cardiovascular events. The incidence of end-stage renal disease is expected to increase. Despite of the technical improvement, dialysis never achieved a full clearance of the blood dialysis. Therefore, the demand for new renoprotective measures has never been greater. Here, we report new strategies for preventing renal damage.
March 25, 2024: World Journal of Nephrology
https://read.qxmd.com/read/38593046/design-and-biological-evaluation-of-the-long-acting-c5-inhibited-ornithodoros-moubata-complement-inhibitor-omci-modified-with-fatty-acid
#29
JOURNAL ARTICLE
Wenwen Shangguan, Xiaowan Li, Yandan Wang, Zongqing Huang, Yuanzhen Dong, Meiqing Feng, Jun Feng
Disorder of complement response is a significant pathogenic factor causing some autoimmune and inflammation diseases. The Ornithodoros moubata Complement Inhibitor (OmCI), a small 17 kDa natural protein, was initially extracted from soft tick salivary glands. The protein was found binding to complement C5 specifically, inhibiting the activation of the complement pathway, which is a successful therapeutic basis of complement-mediated diseases. However, a short half-life due to rapid renal clearance is a common limitation of small proteins for clinical application...
April 9, 2024: Bioconjugate Chemistry
https://read.qxmd.com/read/38590684/effect-of-high-doses-of-salep-aqueous-extract-on-serum-levels-of-urea-nitrogen-creatinine-uric-acid-and-kidney-histopathological-changes-in-adult-male-wistar-rats
#30
JOURNAL ARTICLE
Atashpour Shekoufeh, Abedi Hassanali, Shafiei Jahromi Nazanin, Bagherzadeh Mohammad Aref, Saremi Jamileh, Mahjour Amirashkan, Kargar Jahromi Hossein
Kidneys are critical in the clearance and maintenance of active metabolites. One of the medical properties of Salep is treating bladder and kidney inflammation. Due to the widespread use of Salep in traditional medicine and the food industry, and since the effects of Salep on kidney function have not been studied, the present study aimed to investigate the impact of Salep on kidney function. In this experimental study, 48 male rats were divided randomly into six groups as control, sham, and four experimental groups receiving different doses of Salep intraperitoneally (80, 160, 320, and 640 mg/kg)...
October 2023: Archives of Razi Institute
https://read.qxmd.com/read/38590637/kinetic-modeling-of-the-plasma-pharmacokinetic-profiles-of-adamts13-fragment-and-its-fc-fusion-counterpart-in-mice
#31
JOURNAL ARTICLE
Heechun Kwak, Min-Soo Kim, Suyong Kim, Jiyoung Kim, Yasunori Aoki, Suk-Jae Chung, Hyun-Ja Nam, Wooin Lee
Introduction: Fusion of the fragment crystallizable (Fc) to protein therapeutics is commonly used to extend the circulation time by enhancing neonatal Fc-receptor (FcRn)-mediated endosomal recycling and slowing renal clearance. This study applied kinetic modeling to gain insights into the cellular processing contributing to the observed pharmacokinetic (PK) differences between the novel recombinant ADAMTS13 fragment (MDTCS) and its Fc-fusion protein (MDTCS-Fc). Methods: For MDTCS and MDTCS-Fc, their plasma PK profiles were obtained at two dose levels following intravenous administration of the respective proteins to mice...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38586805/safety-and-efficacy-of-percutaneous-nephrolithotomy-in-solitary-functioning-kidneys-a-retrospective-cohort-study-in-an-asian-population
#32
JOURNAL ARTICLE
Muhammad Shoaib Mithani, Wajahat Fareed, Neha Asif, Mishquat Shabbir
Objective The aim of the study was to assess the safety of preserved renal function after standard percutaneous nephrolithotomy (PCNL) in patients with a single functional kidney. The main parameters to focus on were serum creatinine levels and any associated complications. Materials and methods This retrospective cohort study was conducted in an Eastern population in a single center from 2016 through 2023 at The Kidney Centre Postgraduate Training Institute, Karachi, Pakistan. Results Out of the total 1,550 PCNL procedures performed on adult patients, 47 patients had a solitary functioning kidney with stones, which were evaluated...
March 2024: Curēus
https://read.qxmd.com/read/38585959/paraneoplastic-renal-dysfunction-in-fly-cancer-models-driven-by-inflammatory-activation-of-stem-cells
#33
Sze Hang Kwok, Yuejiang Liu, David Bilder, Jung Kim
UNLABELLED: Tumors can induce systemic disturbances in distant organs, leading to physiological changes that enhance host morbidity. In Drosophila cancer models, tumors have been known for decades to cause hypervolemic 'bloating' of the abdominal cavity. Here we use allograft and transgenic tumors to show that hosts display fluid retention associated with autonomously defective secretory capacity of fly renal tubules, which function analogous to those of the human kidney. Excretion from these organs is blocked by abnormal cells that originate from inappropriate activation of normally quiescent renal stem cells (RSCs)...
March 25, 2024: bioRxiv
https://read.qxmd.com/read/38584147/effects-of-low-flux-and-high-flux-hemodialysis-on-the-survival-of-elderly-maintenance-hemodialysis-patients
#34
JOURNAL ARTICLE
Wanqing Huang, Jiuxu Bai, Yanping Zhang, Dongxia Qiu, Lin Wei, Chen Zhao, Zhuo Ren, Qian Wang, Kaiming Ren, Ning Cao
BACKGROUND: Elderly hemodialysis (HD) patients have a high risk of death. The effect of different types of HD membranes on survival is still controversial. The purpose of this study was to determine the relationship between the use of low-flux or high-flux membranes and all-cause and cardiovascular mortality in elderly hemodialysis patients. METHODS: This was a retrospective clinical study involving maintenance hemodialysis patients which were categorized into low-flux and high-flux groups according to the dialyzer they were using...
December 2024: Renal Failure
https://read.qxmd.com/read/38583388/predicting-muscarinic-receptor-occupancy-in-human-bladder-mucosa-from-urinary-concentrations-of-antimuscarinic-agents-for-overactive-bladder
#35
JOURNAL ARTICLE
Mizuki Shiho, Gaku Akashita, Eriko Nakatani, Shimako Tanaka, Shizuo Yamada, Takashi Okura
To assess the pharmacologically relevant and selective muscarinic receptor occupancy in the bladder mucosa, we considered not only plasma drug concentrations but also urinary drug concentrations. The purpose of this study was to predict muscarinic receptor occupancy in the human bladder mucosa based on urinary concentrations in response to clinical dosages of antimuscarinic agents used to treat overactive bladder. The calculated mean plasma or serum unbound steady state concentrations were 0.06-11 nM in clinical dosages of five antimuscarinic agents...
January 15, 2024: Drug Metabolism and Pharmacokinetics
https://read.qxmd.com/read/38582343/potential-impact-of-underlying-diseases-influencing-adme-in-nonclinical-safety-assessment
#36
REVIEW
Sumin Cho, Harin Jo, Yeon Jeong Hwang, Changuk Kim, Yong Hyeon Jo, Jun-Won Yun
Nonclinical studies involve in vitro, in silico, and in vivo experiments to assess the toxicokinetics, toxicology, and safety pharmacology of drugs according to regulatory requirements by a national or international authority. In this review, we summarize the potential effects of various underlying diseases governing the absorption, distribution, metabolism, and excretion (ADME) of drugs to consider the use of animal models of diseases in nonclinical trials. Obesity models showed alterations in hepatic metabolizing enzymes, transporters, and renal pathophysiology, which increase the risk of drug-induced toxicity...
April 4, 2024: Food and Chemical Toxicology
https://read.qxmd.com/read/38578394/population-pharmacokinetics-of-sacituzumab-govitecan-in-patients-with-metastatic-triple-negative-breast-cancer-and-other-solid-tumors
#37
JOURNAL ARTICLE
Abhishek G Sathe, Indrajeet Singh, Pratap Singh, Paul M Diderichsen, Xiaohui Wang, Peter Chang, Atiya Taqui, See Phan, Sandhya Girish, Ahmed A Othman
BACKGROUND AND OBJECTIVE: Sacituzumab govitecan (SG) is an antibody-drug conjugate composed of an antibody with affinity for Trop-2 coupled to SN-38 via hydrolyzable linker. SG is approved for patients with metastatic triple-negative breast cancer (mTNBC) who have received two or more prior chemotherapies (at least one in a metastatic setting) and for patients with pretreated hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer...
April 5, 2024: Clinical Pharmacokinetics
https://read.qxmd.com/read/38570033/safety-and-efficacy-of-nivolumab-therapy-in-patients-with-metastatic-renal-cell-carcinoma-and-impaired-kidney-function
#38
REVIEW
N Sengul, I Gültürk, M Yilmaz, E Celik, N Paksoy, E Yekedüz, Y Ürün, M Basaran, M Özgüroğlu
INTRODUCTION: Patients with renal insufficiency, usually defined as those with creatinine clearance <40 mL/min, were excluded from pivotal clinical trials, especially in studies involving nivolumab therapy in patients with renal cell carcinoma (RCC).The aim of the study is to evaluate the efficacy and safety of nivolumab in patients with metastatic RCC (mRCC) stratified according to creatinine clearance. MATERIAL AND METODS: Data from mRCC patients treated with nivolumab were retrospectively analyzed...
April 1, 2024: Actas urologicas españolas
https://read.qxmd.com/read/38567754/role-of-mitochondria-in-renal-ischemia-reperfusion-injury
#39
REVIEW
Ruizhen Huang, Chiyu Zhang, Zhengjie Xiang, Tao Lin, Jian Ling, Honglin Hu
Acute kidney injury (AKI) induced by renal ischemia-reperfusion injury (IRI) has a high morbidity and mortality, representing a worldwide problem. The kidney is an essential organ of metabolism that has high blood perfusion and is the second most mitochondria-rich organ after the heart because of the high ATP demands of its essential functions of nutrient reabsorption, acid-base and electrolyte balance, and hemodynamics. Thus, these energy-intensive cells are particularly vulnerable to mitochondrial dysfunction...
April 3, 2024: FEBS Journal
https://read.qxmd.com/read/38566931/slap-trial-shock-wave-lithotripsy-and-mechanical-percussion-therapy-post-eswl-for-renal-calculi
#40
JOURNAL ARTICLE
Nishal Patel, Adrian Roe, Donna Stanton, Jay Roberts, Akshay Kothari
METHODS: We conducted a prospective randomised control trial. Included patients were males and females greater than 18 years of age with single or multiple ipsilateral renal calculi of total ≤10 mm on plain X-ray and noncontrast CT KUB. ESWL was performed at a single centre, at supine position under general anaesthesia with maximum 3000 shocks at a rate of 100 shocks per minute. Patients were discharged and randomised to either the control arm or MPI therapy. MPI therapy was self-directed in a home setting for 10 minutes a day, three times per week...
2024: Advances in Urology
keyword
keyword
104396
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.